(Q44967246)

7 December 2017

title

Breast cancer incidence by estrogen receptor status in Denmark from 1996 to 2007. (English)

1 reference

7 December 2017

0 references

J Bigaard

1

1 reference

7 December 2017

C Stahlberg

2

1 reference

7 December 2017

M-B Jensen

3

1 reference

7 December 2017

M Ewertz

4

1 reference

7 December 2017

N Kroman

5

1 reference

7 December 2017

language of work or name

English

0 references

publication date

30 September 2012

1 reference

Breast Cancer Research and Treatment

7 December 2017

published in

1 reference

7 December 2017

volume

136

1 reference

7 December 2017

issue

2

1 reference

7 December 2017

page(s)

559-564

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-012-2269-0

7 December 2017

exact match

0 references

cites work

Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Incidence of breast cancer in the United States: current and future trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

The decrease in breast-cancer incidence in 2003 in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Sustained lower rates of breast cancer in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Shifting breast cancer trends in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Breast cancer after use of estrogen plus progestin in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Breast cancer incidence and use of hormone therapy in Denmark 1978-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Breast cancer incidence and hormone replacement therapy in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Decline in breast cancer incidence in the Flemish region of Belgium after a decline in hormonal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Incidence of female breast cancer in relation to prevalence of risk factors in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Development in incidence of breast cancer in non-screened Danish women, 1973-2002--a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Hormone replacement therapy in Denmark, 1995-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Estrogen Receptor analyses in the Danish Breast Cancer Cooperative Group. History, methods, prognosis and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Epidemiology and the causes of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

Breast cancer incidence rates in U.S. women are no longer declining

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2269-0

10.1007/S10549-012-2269-0

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference